{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:23:38Z","timestamp":1766690618213,"version":"3.48.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Atopic dermatitis is a risk factor for venous thromboembolism which may be the first manifestation of occult cancer. We examined whether a venous thromboembolism in patients with atopic dermatitis is a marker of occult cancer. We used Danish health registries to conduct this population-based cohort study. Patients with a first-time diagnosis of venous thromboembolism and a history of atopic dermatitis were identified from the Danish National Patients Registry from 1980 through 2022. We calculated the absolute risk of cancer treating death as a competing event. As a measure of relative risk, we calculated standardized incidence ratios (SIRs) for cancer among patients with venous thromboembolism and atopic dermatitis and compared the observed cancer incidence to that of the general Danish population. We identified 582 patients with a first venous thromboembolism diagnosis and a history of atopic dermatitis. During the first year of follow\u2010up, the absolute risk of overall cancer was 1.7%, corresponding to an SIR of 2.90 (95% confidence interval [CI] 1.39\u20135.34). The overall SIR decreased to 1.12 (95% CI 0.74\u20131.62) during the subsequent years of follow\u2010up. Although the risk estimates were imprecise, an elevated cancer risk following venous thromboembolism in patients with atopic dermatitis cannot be ruled out, particularly within the first year after venous thromboembolism, when compared to the cancer risk in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p>Atopic dermatitis, venous thromboembolism and cancer: a cohort analysis. VTE, venous thromboembolism; AD, atopic dermatitis; CI, confidence interval<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11239-025-03175-2","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:20:35Z","timestamp":1756995635000},"page":"1120-1126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atopic dermatitis, venous thromboembolism and cancer: a cohort analysis"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9243-9736","authenticated-orcid":false,"given":"Sissel Brandt Toft","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2789-5003","authenticated-orcid":false,"given":"Cecilia H.","family":"Fuglsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-2212","authenticated-orcid":false,"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"10063","key":"3175_CR1","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0140-6736(16)30514-1","volume":"388","author":"M Di Nisio","year":"2016","unstructured":"Di Nisio M, van Es N, B\u00fcller HR (2016) Deep vein thrombosis and pulmonary embolism. Lancet 388(10063):3060\u20133073. https:\/\/doi.org\/10.1016\/S0140-6736(16)30514-1","journal-title":"Lancet"},{"issue":"4","key":"3175_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","volume":"5","author":"IA Naess","year":"2007","unstructured":"Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstr\u00f8m J (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5(4):692\u2013699. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02450.x","journal-title":"J Thromb Haemost"},{"issue":"10","key":"3175_CR3","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","volume":"8","author":"MJ Engbers","year":"2010","unstructured":"Engbers MJ, van Hylckama Vlieg A, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8(10):2105\u20132112. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03986.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3175_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/rth2.12101","volume":"2","author":"LJJ Scheres","year":"2018","unstructured":"Scheres LJJ, Lijfering WM, Cannegieter SC (2018) Current and future burden of venous thrombosis: not simply predictable. Res Pract Thromb Haemost 2(2):199\u2013208. https:\/\/doi.org\/10.1002\/rth2.12101","journal-title":"Res Pract Thromb Haemost"},{"issue":"9","key":"3175_CR5","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1182\/blood-2007-06-096545","volume":"110","author":"RL Silverstein","year":"2007","unstructured":"Silverstein RL, Bauer KA, Cushman M, Esmon CT, Ershler WB, Tracy RP (2007) Venous thrombosis in the elderly: more questions than answers. Blood 110(9):3097\u20133101. https:\/\/doi.org\/10.1182\/blood-2007-06-096545","journal-title":"Blood"},{"issue":"16","key":"3175_CR6","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJM199210153271604","volume":"327","author":"P Prandoni","year":"1992","unstructured":"Prandoni P, Lensing AW, B\u00fcller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten Cate JW (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327(16):1128\u20131133. https:\/\/doi.org\/10.1056\/NEJM199210153271604","journal-title":"N Engl J Med"},{"issue":"1","key":"3175_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00336-y","volume":"8","author":"AA Khorana","year":"2022","unstructured":"Khorana AA, Mackman N, Falanga A, Pabinger I, Noble S, Ageno W, Moik F, Lee AYY (2022) Cancer-associated venous thromboembolism. Nat Rev Dis Primers 8(1):11. https:\/\/doi.org\/10.1038\/s41572-022-00336-y","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"3175_CR8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, Ay C, B\u00fcller HR, S\u00f8rensen HT (2021) Venous thromboembolism in cancer patients: a population-based cohort study. Blood 137(14):1959\u20131969. https:\/\/doi.org\/10.1182\/blood.2020007338","journal-title":"Blood"},{"key":"3175_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.thromres.2016.07.013","volume":"145","author":"AA Khorana","year":"2016","unstructured":"Khorana AA, Yannicelli D, McCrae KR, Milentijevic D, Crivera C, Nelson WW, Schein JR (2016) Evaluation of US prescription patterns: are treatment guidelines for cancer-associated venous thromboembolism being followed? Thromb Res 145:51\u201353. https:\/\/doi.org\/10.1016\/j.thromres.2016.07.013","journal-title":"Thromb Res"},{"key":"3175_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100739","volume":"34","author":"HT S\u00f8rensen","year":"2023","unstructured":"S\u00f8rensen HT, Pedersen L, van Es N, B\u00fcller HR, Horv\u00e1th-Puh\u00f3 E (2023) Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study. Lancet Reg Health 34:100739. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100739","journal-title":"Lancet Reg Health"},{"issue":"25","key":"3175_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"343","author":"HT S\u00f8rensen","year":"2000","unstructured":"S\u00f8rensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343(25):1846\u20131850. https:\/\/doi.org\/10.1056\/NEJM200012213432504","journal-title":"N Engl J Med"},{"issue":"10247","key":"3175_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345\u2013360. https:\/\/doi.org\/10.1016\/S0140-6736(20)31286-1","journal-title":"Lancet"},{"issue":"1","key":"3175_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11239-024-03038-2","volume":"58","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Z, He T, Huang C, Shen C (2025) Risk of incident venous thromboembolism in patients with atopic dermatitis: systematic analysis of the literature and meta-analysis. J Thromb Thrombolysis 58(1):126\u2013135. https:\/\/doi.org\/10.1007\/s11239-024-03038-2","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"3175_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.det.2024.06.001","volume":"42","author":"DL Drum","year":"2024","unstructured":"Drum DL, Wan LS, Jallorina AG, Lee-Wong MF (2024) Exploring the association between atopic dermatitis and malignancy: a comprehensive review with therapeutic strategies. Dermatol Clin 42(4):625\u2013634. https:\/\/doi.org\/10.1016\/j.det.2024.06.001","journal-title":"Dermatol Clin"},{"issue":"6","key":"3175_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s13555-025-01375-5","volume":"15","author":"AR Lemeshow","year":"2025","unstructured":"Lemeshow AR, Egeberg A, Edwards T, Schachterle SE, Romero W, Myers DE, Vyas S, Silverberg JI (2025) The association between atopic dermatitis and select disease events in adults in the United States: a retrospective cohort study in the Optum electronic health records database. Dermatol Ther (Heidelb) 15(6):1371\u20131390. https:\/\/doi.org\/10.1007\/s13555-025-01375-5","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"3175_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/11593280-000000000-00000","volume":"13","author":"AO Jensen","year":"2012","unstructured":"Jensen AO, Svaerke C, K\u00f6rmendin\u00e9 Farkas D, Olesen AB, Kragballe K, S\u00f8rensen HT (2012) Atopic dermatitis and risk of skin cancer: a Danish nationwide cohort study (1977\u20132006). Am J Clin Dermatol 13(1):29\u201336. https:\/\/doi.org\/10.2165\/11593280-000000000-00000","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"3175_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/jamadermatol.2019.3786","volume":"156","author":"L Wang","year":"2020","unstructured":"Wang L, Bierbrier R, Drucker AM, Chan AW (2020) Noncutaneous and cutaneous cancer risk in patients with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol 156(2):158\u2013171. https:\/\/doi.org\/10.1001\/jamadermatol.2019.3786","journal-title":"JAMA Dermatol"},{"key":"3175_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundb\u00f8ll J, Laugesen K, Ehrenstein V, S\u00f8rensen HT (2019) The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol 11:563\u2013591. https:\/\/doi.org\/10.2147\/CLEP.S179083","journal-title":"Clin Epidemiol"},{"issue":"8","key":"3175_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT (2014) The danish civil registration system as a tool in epidemiology. Eur J Epidemiol 29(8):541\u2013549. https:\/\/doi.org\/10.1007\/s10654-014-9930-3","journal-title":"Eur J Epidemiol"},{"key":"3175_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT (2015) The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol 7:449\u2013490. https:\/\/doi.org\/10.2147\/CLEP.S91125","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"3175_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML (2011) The Danish Cancer Registry. Scand J Public Health 39(7 Suppl):42\u201345. https:\/\/doi.org\/10.1177\/1403494810393562","journal-title":"Scand J Public Health"},{"issue":"2","key":"3175_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jclinepi.2009.03.018","volume":"63","author":"MT Severinsen","year":"2010","unstructured":"Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tj\u00f8nneland A, Johnsen SP (2010) Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 63(2):223\u2013228. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.03.018","journal-title":"J Clin Epidemiol"},{"key":"3175_CR23","unstructured":"dos Santos Silva I (1999) Cohort studies. In: Cancer Epidemiology: Principles and Methods. International Agency for Research on Cancer (IARC), Lyon, pp 165\u2013186"},{"key":"3175_CR24","unstructured":"Rothman KJ, Boice JD (1979) Epidemiologic Analysis with a Programmable Calculator. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health"},{"issue":"4","key":"3175_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jdiacomp.2016.01.011","volume":"30","author":"DH Christensen","year":"2016","unstructured":"Christensen DH, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Knudsen ST, Dekkers O, Prandoni P, S\u00f8rensen HT (2016) Venous thromboembolism and risk of cancer in patients with diabetes mellitus. J Diabetes Complications 30(4):603\u2013607. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.01.011","journal-title":"J Diabetes Complications"},{"issue":"1","key":"3175_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2015-000043","volume":"2","author":"J Montomoli","year":"2015","unstructured":"Montomoli J, Erichsen R, S\u00f8gaard KK, K\u00f6rmendin\u00e9 Farkas D, Bloch M\u00fcnster AM, S\u00f8rensen HT (2015) Venous thromboembolism and subsequent risk of cancer in patients with liver disease: a population-based cohort study. BMJ Open Gastroenterol 2(1):e000043. https:\/\/doi.org\/10.1136\/bmjgast-2015-000043","journal-title":"BMJ Open Gastroenterol"},{"issue":"8","key":"3175_CR27","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3390\/jcm9082389","volume":"9","author":"J D'Astous","year":"2020","unstructured":"D\u2019Astous J, Carrier M (2020) Screening for occult cancer in patients with venous thromboembolism. J Clin Med 9(8):2389. https:\/\/doi.org\/10.3390\/jcm9082389","journal-title":"J Clin Med"},{"issue":"45","key":"3175_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036050","volume":"102","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang M (2023) Smoking and the risk of atopic dermatitis: a two-sample mendelian randomization study. Medicine (Baltimore) 102(45):e36050. https:\/\/doi.org\/10.1097\/MD.0000000000036050","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"3175_CR29","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/jth.13791","volume":"15","author":"A Delluc","year":"2017","unstructured":"Delluc A, Antic D, Lecumberri R, Ay C, Meyer G, Carrier M (2017) Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost 15(10):2076\u20132079. https:\/\/doi.org\/10.1111\/jth.13791","journal-title":"J Thromb Haemost"},{"issue":"11","key":"3175_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012832","volume":"6","author":"J Sundb\u00f8ll","year":"2016","unstructured":"Sundb\u00f8ll J, Adelborg K, Munch T, Fr\u00f8slev T, S\u00f8rensen HT, B\u00f8tker HE, Schmidt M (2016) Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 6(11):e012832. https:\/\/doi.org\/10.1136\/bmjopen-2016-012832","journal-title":"BMJ Open"},{"key":"3175_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-83","volume":"11","author":"SK Thygesen","year":"2011","unstructured":"Thygesen SK, Christiansen CF, Christensen S, Lash TL, S\u00f8rensen HT (2011) The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 11:83. https:\/\/doi.org\/10.1186\/1471-2288-11-83","journal-title":"BMC Med Res Methodol"},{"key":"3175_CR32","unstructured":"American Cancer Society medical and editorial content team, Health Risks of Smoking Tobacco, https:\/\/www.cancer.org\/cancer\/risk-prevention\/tobacco\/health-risks-of-smoking-tobacco.html (last revised: November 19, 2024)"},{"issue":"6","key":"3175_CR33","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.jaad.2019.08.039","volume":"83","author":"SAJ Schmidt","year":"2020","unstructured":"Schmidt SAJ, Olsen M, Schmidt M, Vestergaard C, Langan SM, Deleuran MS, Riis JL (2020) Atopic dermatitis and risk of atrial fibrillation or flutter: a 35-year follow-up study. J Am Acad Dermatol 83(6):1616\u20131624. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.039","journal-title":"J Am Acad Dermatol"},{"key":"3175_CR34","volume-title":"Epidemiology: an introduction","author":"KJ Rothman","year":"2021","unstructured":"Rothman KJ, Huybrechts KF, Murray EJ (2021) Epidemiology: an introduction, 3rd edn. Oxford University Press, New York","edition":"3"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03175-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03175-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03175-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T18:11:42Z","timestamp":1766686302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03175-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3175"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03175-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"21 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Danish Data Protection Agency at Aarhus University (no. 2016\u2013051-000001\u2013812). According to Danish law, registry-based studies do not require informed consent or approval from ethics committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}